Seeking Alpha

More on GSK  (GSK -1.3%) Q2: Earnings hurt by government austerity in Europe, where sales...

More on GSK  (GSK -1.3%) Q2: Earnings hurt by government austerity in Europe, where sales fell 8%, and competition from cheaper generics in the U.S. GSK expresses confidence that its diversification, new products and expansion in emerging markets makes its future bright. Expects FY sales to be in line with 2011, and to repurchase £2-2.5B in stock.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|